Permalink
Switch branches/tags
Nothing to show
Find file
Fetching contributors…
Cannot retrieve contributors at this time
19 lines (18 sloc) 1.29 KB

For 30 years we thought that the only way to defeat cancer was to kill the cancer cells. Brian Druker came up with a novel approach to fighting cancer in the form of a drug called Glevac. Glevac doesn't involve the traditional side affects of cancer treatments like chemotherapy. With cancer causing 1 in 4 deaths in our country, Glevac is a drug that could completely change how we treat those with cancer. The innovative strategy Glevac employs is figuring out the actual cause of a specific cancer; If the cause has been discovered, then there is hope for a cure. Glevac can actually be used to cure 10 different kinds of cancer (all the cured cancers share a common cause). To discover the causes of cancer (every cancer is different) Druker suggested that we invest a lot more resources that are currently being allocated to cancer research. He pointed out that cancer research is splintered into competeing labs that don't work together and instead focus on their own research. Another thing I learned from Druker's talk was that it is very expensive to develop a drugs and drug development is a very risky investment for drug companies. Druker said developing a single drug can cost anywhere between $500 million to $1 Billion and that there is a 1 in 10 chance of the drug being successful being successful